Compartmentalization of the immune response in the central nervous system and natural history of multiple sclerosis. Implications for therapy

Clinical Neurology and Neurosurgery

Volumn 104, Issue 3, 2002, Pages 177-181

  Massacesi, Luca ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Compartmentalization; Immunology; MRI; Pathogenesis

Indexed keywords

AZATHIOPRINE; BETA INTERFERON; CYCLOPHOSPHAMIDE; MYELIN;

ALLERGIC ENCEPHALITIS; BLOOD BRAIN BARRIER; BRAIN REGION; CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; INFLAMMATION; MULTIPLE SCLEROSIS; NEUROPATHOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; T LYMPHOCYTE;

BLOOD-BRAIN BARRIER; CENTRAL NERVOUS SYSTEM DISEASES; CYCLOPHOSPHAMIDE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS;

EID: 0036074477     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-8467(02)00035-5     Document Type: Conference Paper

References (29)

1. Demyelinating diseases
2. A new primate model for multiple sclerosis
3. The neuropathology of multiple sclerosis
4. Mechanism of demyelination and tissue destruction in multiple sclerosis
5. Distinct patterns of multiple sclerosis pathology indicate heterogeneity of pathogenesis
6. Axonal transection in the lesions of multiple sclerosis
7. Correlation of magnetic resonance imaging parameters with clinical disability in multiple sclerosis: a preliminary study
8. Identification of autoantibodies associated with myelin damage in multiple sclerosis
9. Clinical usefulness of oligoclonal bands
10. Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis
11. Accumulation of clonally related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients
12. Oligoclonal T-cell repertoire in cerebrospinal fluid of patients with nervous system inflammatory diseases
13. T-cell apoptosis in autoimmune diseases: termination of inflammation in the nervous system and other sites with specialized immune-defense mechanisms
14. Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction
15. Monocyte/macrophage differentiation in early multiple sclerosis lesions
16. Two subsets of dendritic cells are present in human cerebrospinal fluid
17. Intracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune encephalomyelitis
18. Lymphoid tissue and organs
19. Immunopathology of secondary progressive multiple sclerosis
20. The lesion in multiple sclerosis: clinical, pathological, and magnetic resonance imaging considerations
21. Serial gadolinium-enhanced and magnetization transfer imaging to investigate the relationship between the duration of blood-brain barrier disruption and extent of demyelination in new multiple sclerosis lesions
22. Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology
23. Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p)reactive lesions
24. Spatial mapping of T2 and gadolinium-enhancing T1 lesion volumes in multiple sclerosis: evidence for distinct mechanisms of lesion genesis
25. T1 lesion load and cerebral atrophy as a marker for clinical progression in patients with multiple sclerosis. A prospective 18 months follow-up study
26. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis
27. Histopathological characterization of magnetic resonance imaging-detectable brain white matter lesions in a primate model of multiple sclerosis: a correlative study in the experimental autoimmune encephalomyelitis model in common marmosets (Callithrix jacchus)
28. MRI evaluation of azathioprine activity on encephalic lesions in relapsing-remitting multiple sclerosis
29. Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment Group